Keros Therapeutics, Inc. (KROS) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$10.87
Day's range
$11.56

Keros Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 08/07/2026 2.79 M $29.90 M   15.86% 14.11%
NANTAHALA CAPITAL MANAGEMENT, LLC 08/19/2026 1.41 M $15.09 M   3.68% 7.12%
AQR CAPITAL MANAGEMENT LLC 08/14/2026 967.86 K $10.36 M   138.06% 4.89%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 833.60 K $8.92 M   0.26% 4.21%
ORBIMED ADVISORS LLC 08/14/2026 759.16 K $8.12 M   0.00% 3.83%
FEDERATED HERMES, INC. 08/12/2026 700.43 K $7.49 M   1.62% 3.54%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 652.64 K $6.98 M   -4.31% 3.30%
MACKENZIE FINANCIAL CORP 08/13/2026 628.44 K $6.72 M   312.23% 3.17%
MADISON AVENUE PARTNERS, LP 08/14/2026 626.58 K $6.70 M   0.00% 3.16%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 608.84 K $6.51 M   -16.01% 3.07%
JACOBS LEVY EQUITY MANAGEMENT, INC 08/14/2026 605.45 K $6.48 M   -14.25% 3.06%
STATE STREET CORP 08/07/2026 541.19 K $5.79 M   -3.66% 2.73%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 510.84 K $5.47 M   -25.04% 2.58%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 460.54 K $4.93 M   43.31% 2.33%
CITADEL ADVISORS LLC 09/02/2026 396.10 K $4.24 M   -2.60% 2.00%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 359.09 K $3.84 M   -20.82% 1.81%
D. E. SHAW & CO., INC. 08/14/2026 267.46 K $2.86 M   -47.52% 1.35%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 08/14/2026 265.02 K $2.84 M   35.89% 1.34%
NUVEEN, LLC 08/11/2026 247.76 K $2.65 M   -5.46% 1.25%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 246.82 K $2.64 M   153.62% 1.25%
TWO SIGMA INVESTMENTS, LP 08/14/2026 246.65 K $2.64 M   -32.21% 1.25%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 08/13/2026 233.18 K $2.49 M   -60.50% 1.18%
MILLENNIUM MANAGEMENT LLC 08/14/2026 184.82 K $1.98 M   72.96% 0.93%
GOLDMAN SACHS GROUP INC 08/14/2026 177.85 K $1.90 M   -20.77% 0.90%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 158.71 K $1.70 M   -11.80% 0.80%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 158.71 K $1.70 M   100.00% 0.80%
MAN GROUP PLC 08/14/2026 155.54 K $1.66 M   -34.82% 0.79%
WELLS FARGO & COMPANY/MN 08/14/2026 155.48 K $1.66 M   2.94% 0.79%
NORTHERN TRUST CORP 08/13/2026 153.84 K $1.65 M   -39.48% 0.78%
BESSEMER GROUP INC 08/12/2026 143.85 K $1.54 M   0.00% 0.73%
EMPOWERED FUNDS, LLC 08/17/2026 142.15 K $1.52 M   -2.31% 0.72%
UBS GROUP AG 08/13/2026 137.99 K $1.48 M   -5.21% 0.70%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 131.31 K $1.41 M   3.15% 0.66%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 08/13/2026 127.89 K $1.37 M   -50.41% 0.65%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 08/13/2026 126.38 K $1.35 M   100.00% 0.64%
ACADIAN ASSET MANAGEMENT LLC 08/13/2026 115.62 K $1.23 M   76.69% 0.58%
JANE STREET GROUP, LLC 08/14/2026 115.27 K $1.23 M   159.28% 0.58%
BANK OF NEW YORK MELLON CORP 08/06/2026 103.34 K $1.11 M   -14.56% 0.52%
AMERIPRISE FINANCIAL INC 08/14/2026 101.34 K $1.08 M   -1.11% 0.51%
AMERICAN CENTURY COMPANIES INC 08/12/2026 84.68 K $906.08 K   31.78% 0.43%
LOS ANGELES CAPITAL MANAGEMENT LLC 08/13/2026 84.37 K $902.78 K   -51.00% 0.43%
MORGAN STANLEY 08/13/2026 79.29 K $848.37 K   -36.12% 0.40%
INVESCO LTD. 08/14/2026 71.56 K $765.72 K   -18.47% 0.36%
HSBC HOLDINGS PLC 08/14/2026 69.93 K $761.49 K   29.53% 0.35%
MARTINGALE ASSET MANAGEMENT L P 08/13/2026 67.80 K $725.42 K   42.44% 0.34%
PRINCIPAL FINANCIAL GROUP INC 08/04/2026 63.81 K $682.74 K   7.07% 0.32%
RBF CAPITAL, LLC 08/14/2026 62.80 K $671.96 K   0.00% 0.32%
RUSSELL INVESTMENTS GROUP, LTD. 08/06/2026 60.89 K $651.55 K   -25.11% 0.31%
XTX TOPCO LTD 08/14/2026 59.53 K $636.98 K   -32.60% 0.30%
JAIN GLOBAL LLC 08/14/2026 59.21 K $633.54 K   100.00% 0.30%

Keros Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 192 institutional investors and hedge funds held shares of Keros Therapeutics Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 2.79 M

Nantahala Capital Management, LLC: 1.41 M

AQR CAPITAL MANAGEMENT LLC: 967,859

VANGUARD CAPITAL MANAGEMENT LLC: 833,596

ORBIMED ADVISORS LLC: 759,155

FEDERATED HERMES, INC.: 700,427

94.51% of Keros Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 23.79 M shares in the last 24 months. This purchase volume represents approximately $270.03 M in transactions.